Cintas [CTAS] vs Ul Solutions [ULS] Detailed Stock Comparison
Cintas
NASDAQ
Loading...
Ul Solutions
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Cintas wins in 12 metrics, Ul Solutions wins in 7 metrics, with 0 ties. Cintas appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Cintas | Ul Solutions | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 48.81 | 41.25 | Ul Solutions |
| Price-to-Book Ratio | 18.43 | 12.28 | Ul Solutions |
| Debt-to-Equity Ratio | 56.67 | 72.33 | Cintas |
| PEG Ratio | 45.79 | -3.51 | Ul Solutions |
| EV/EBITDA | 32.66 | 23.00 | Ul Solutions |
| Profit Margin (TTM) | 17.53% | 11.08% | Cintas |
| Operating Margin (TTM) | 22.40% | 17.78% | Cintas |
| EBITDA Margin (TTM) | 22.40% | 17.78% | Cintas |
| Return on Equity | 40.27% | 36.55% | Cintas |
| Return on Assets (TTM) | 15.53% | 10.77% | Cintas |
| Free Cash Flow (TTM) | $1.76B | $287.00M | Cintas |
| Dividend Yield | 0.90% | 0.52% | Cintas |
| 1-Year Return | 9.63% | 19.39% | Ul Solutions |
| Price-to-Sales Ratio (TTM) | 8.35 | 4.55 | Ul Solutions |
| Enterprise Value | $88.74B | $14.03B | Cintas |
| EV/Revenue Ratio | 8.58 | 4.76 | Ul Solutions |
| Gross Profit Margin (TTM) | 49.71% | 49.36% | Cintas |
| Revenue per Share (TTM) | $26 | $15 | Cintas |
| Earnings per Share (Diluted) | $4.39 | $1.62 | Cintas |
| Beta (Stock Volatility) | 1.02 | N/A | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Cintas vs Ul Solutions Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Cintas | -0.25% | -2.37% | -2.35% | -2.23% | 5.71% | 18.68% |
| Ul Solutions | 0.23% | -2.45% | -6.87% | -8.86% | 23.00% | 31.32% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Cintas | 9.63% | 105.82% | 158.91% | 912.70% | 3,276.72% | 1,990.04% |
| Ul Solutions | 19.39% | 86.61% | 86.61% | 86.61% | 86.61% | 86.61% |
Performance & Financial Health Analysis: Cintas vs Ul Solutions
| Metric | CTAS | ULS |
|---|---|---|
| Market Information | ||
| Market Cap | $86.35B | $13.43B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 1,340,040 | 1,467,890 |
| 90 Day Avg. Volume | 1,408,220 | 892,403 |
| Last Close | $215.58 | $65.35 |
| 52 Week Range | $180.78 - $229.24 | $46.79 - $74.15 |
| % from 52W High | -5.96% | -11.87% |
| All-Time High | $229.24 (Jun 06, 2025) | $74.15 (Jul 31, 2025) |
| % from All-Time High | -5.96% | -11.87% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.08% | 0.06% |
| Quarterly Earnings Growth | 0.08% | -0.10% |
| Financial Health | ||
| Profit Margin (TTM) | 0.18% | 0.11% |
| Operating Margin (TTM) | 0.22% | 0.18% |
| Return on Equity (TTM) | 0.40% | 0.37% |
| Debt to Equity (MRQ) | 56.67 | 72.33 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $11.63 | $5.44 |
| Cash per Share (MRQ) | $0.66 | $1.35 |
| Operating Cash Flow (TTM) | $2.17B | $581.00M |
| Levered Free Cash Flow (TTM) | $1.56B | $244.38M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.90% | 0.52% |
| Last 12-Month Dividend | $2.01 | $0.37 |
Valuation & Enterprise Metrics Analysis: Cintas vs Ul Solutions
| Metric | CTAS | ULS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 48.81 | 41.25 |
| Forward P/E | 45.79 | 39.54 |
| PEG Ratio | 45.79 | -3.51 |
| Price to Sales (TTM) | 8.35 | 4.55 |
| Price to Book (MRQ) | 18.43 | 12.28 |
| Market Capitalization | ||
| Market Capitalization | $86.35B | $13.43B |
| Enterprise Value | $88.74B | $14.03B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 8.58 | 4.76 |
| Enterprise to EBITDA | 32.66 | 23.00 |
| Risk & Other Metrics | ||
| Beta | 1.02 | N/A |
| Book Value per Share (MRQ) | $11.63 | $5.44 |
Financial Statements Comparison: Cintas vs Ul Solutions
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CTAS | ULS |
|---|---|---|
| Revenue/Sales | $2.67B | $705.00M |
| Cost of Goods Sold | $1.34B | $364.00M |
| Gross Profit | $1.33B | $341.00M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $597.45M | $109.00M |
| EBITDA | $721.36M | $154.00M |
| Pre-Tax Income | $575.42M | $94.00M |
| Income Tax | $127.16M | $23.00M |
| Net Income (Profit) | $448.26M | $71.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CTAS | ULS |
|---|---|---|
| Cash & Equivalents | $263.97M | $267.00M |
| Total Current Assets | $3.44B | $998.00M |
| Total Current Liabilities | $1.64B | $804.00M |
| Long-Term Debt | $2.60B | $803.00M |
| Total Shareholders Equity | $4.68B | $984.00M |
| Retained Earnings | $11.80B | $291.00M |
| Property, Plant & Equipment | $3.50B | $1.62B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CTAS | ULS |
|---|---|---|
| Operating Cash Flow | $599.12M | $240.00M |
| Capital Expenditures | $0 | N/A |
| Free Cash Flow | $521.13M | $103.00M |
| Debt Repayment | $-450.00M | $-152.00M |
| Common Stock Repurchase | $-256.67M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | CTAS | ULS |
|---|---|---|
| Shares Short | 5.50M | 2.32M |
| Short Ratio | 3.74 | 3.42 |
| Short % of Float | 0.02% | 0.05% |
| Average Daily Volume (10 Day) | 1,340,040 | 1,467,890 |
| Average Daily Volume (90 Day) | 1,408,220 | 892,403 |
| Shares Outstanding | 402.95M | 200.17M |
| Float Shares | 342.24M | 61.89M |
| % Held by Insiders | 0.15% | 0.01% |
| % Held by Institutions | 0.67% | 1.15% |
Dividend Analysis & Yield Comparison: Cintas vs Ul Solutions
| Metric | CTAS | ULS |
|---|---|---|
| Last 12-Month Dividend | $2.01 | $0.37 |
| Last 12-Month Dividend Yield | 0.90% | 0.52% |
| 3-Year Avg Annual Dividend | $1.51 | $0.16 |
| 3-Year Avg Dividend Yield | 0.22% | 0.27% |
| 3-Year Total Dividends | $4.53 | $0.49 |
| Ex-Dividend Date | Aug 15, 2025 | Feb 28, 2025 |